Adult-Onset Type 1 Diabetes Development Following COVID-19 mRNA Vaccination (Moon et al.): 56-year-old female patient developed hyperglycemia after second dose of COVID-19 mRNA-based vaccination

by Paul Alexander

without a prior history of diabetes; the vaccine consultants, the companies, alphabet health agencies did not ensure proper safety of the gene shots; patients unfortunately gambled & many have lost


‘visited our hospital with uncontrolled hyperglycemia despite administration of oral hyperglycemic agents. Her initial glycated hemoglobin level was high (11.0%), and fasting serum C-peptide level was normal. The fasting serum C-peptide level decreased to 0.269 ng/mL 5 days after admission, and the anti-glutamic acid decarboxylase antibody was positive. The patient was discharged in stable condition with insulin treatment.’